Abscesshttps://en.wikipedia.org/wiki/Abscess
Abscess ke pokello ea boladu bo ahileng ka hara dithishu tsa mmele. Matšoao le matšoao a li-abscesses a kenyelletsa bofubelu, bohloko, mofuthu, le ho ruruha. Ho ruruha ho ka utloahala ho tletse metsi ha ho hatelloa. Sebaka sa bofubelu hangata se fetela ka nģ'ane ho sebaka sa ho ruruha.

Hangata li bakoa ke tšoaetso ea baktheria. Baktheria e atileng haholo e teng ke Staphylococcus aureus e hananang le methicillin. Hangata ho hlahlojoa ha lekhopho la letlalo ho itšetlehile ka hore na le shebahala joang 'me ho tiisoa ka ho le khaola. Ho nka litšoantšo ka ultrasound ho ka ba molemo maemong ao tlhahlobo e sa hlakeheng. Libakeng tse pota-potileng anus, computer tomography (CT) e ka 'na ea e-ba ea bohlokoa ho sheba tšoaetso e tebileng.

Kalafo e tloaelehileng bakeng sa boholo ba letlalo kapa maqeba a linama tse bonolo ke ho le bula le ho ntša metsi ha ho sebelisoa lithibela-mafu. Ho anya boladu ka nale hangata ha hoa lekana.

Li-abscesses tsa letlalo li tloaelehile 'me li atile haholo lilemong tsa morao tjena. Lintho tse kotsi li kenyelletsa tšebeliso ea lithethefatsi ka methapo, 'me litekanyetso li tlalehoa li le holimo ho 65% har'a basebelisi. Ka 2005 United States, batho ba limilione tse 3,2 ba ile ba ea lefapheng la maemo a tšohanyetso bakeng sa ho tsoa lesapo. Australia, batho ba ka bang 13,000 ba ile ba kena sepetlele ka 2008 ka boemo bona.

Kalafo
Ho alafa li-abscesses ka lithethefatsi tse rekisoang ka bongata ho thata maemong a mangata. Haeba matšoao a kang feberu le serame a hlaha hohle 'meleng, ka kopo ikopanye le ngaka kapele kamoo ho ka khonehang.

☆ Liphethong tsa 2022 Stiftung Warentest tse tsoang Jeremane, khotsofalo ea bareki ka ModelDerm e ne e le tlase hanyane ho feta lipuisano tse lefelloang tsa telemedicine.
  • inflamed epidermal cyst. Letheba le letšo le amana le cyst e ka tlaase.
  • Tabeng ena ea ho ruruha ha marameng, monyetla oa ho ba le epidermal cyst le oona o lokela ho nkoa.
  • Mofuta o matla oa Abscess o ka siea lebali. Erythema e fokolang e potolohileng leqeba e bontša hore tšoaetso e boemong ba ho rarolla.
  • Abscess ― matsatsi a mahlano ka mor'a ho seha le ho ntša metsi
  • Letheba le letšo karolong e ka holimo ea lethopa le fana ka maikutlo a epidermal cyst.
References Current Treatment Options for Acute Skin and Skin-structure Infections 30957166 
NIH
Batho ba bangata ba ea likamoreng tsa maemo a tšohanyetso bakeng sa mafu a letlalo a bakoang ke baktheria. Staphylococcus aureus ke kokoana-hloko e ka sehloohong e bakang mafu ana, 'me ho ntse ho thatafala ho alafa ka lebaka la ho hlaha ha community-associated methicillin-resistant Staphylococcus aureus (MRSA) .
Acute bacterial skin and skin-structure infections are a common reason for seeking care at acute healthcare facilities, including emergency departments. Staphylococcus aureus is the most common organism associated with these infections, and the emergence of community-associated methicillin-resistant Staphylococcus aureus (MRSA) has represented a considerable challenge in their treatment.
 Prevalence and Therapies of Antibiotic-Resistance in Staphylococcus aureus 32257966 
NIH
Staphylococcus aureus e ka aroloa ka mefuta e 'meli ho latela karabelo ea bona ho lithibela-mafu: methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA) . Lilemong tse mashome a seng makae tse fetileng, ka lebaka la ho iphetola ha baktheria le tšebeliso e feteletseng ea lithibela-mafu, khanyetso ea S. Aureus ho lithethefatsi e ntse e eketseha, e leng se lebisang keketsehong ea lefats'e ea MRSA # litekanyetso tsa ts'oaetso.
According to the sensitivity to antibiotic drugs, S. aureus can be divided into methicillin-sensitive Staphylococcus aureus (MSSA) and methicillin-resistant Staphylococcus aureus (MRSA). In recent decades, due to the evolution of bacteria and the abuse of antibiotics, the drug resistance of S. aureus has gradually increased, the infection rate of MRSA has increased worldwide.
 Treatment of severe skin and soft tissue infections: a review 29278528 
NIH
To review the salient features of the management of severe skin and soft tissue infections (SSTIs), including toxic shock syndrome, myonecrosis/gas gangrene, and necrotizing fasciitis.